open access
Vol 57, No 1 (2023)
Invited Editorial
Submitted: 2022-11-30
Accepted: 2022-12-02
Published online: 2022-12-14
Get Citation
Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19
1, 2
Affiliations- Department of Applied Physical Therapy, Federal University of Triangulo Mineiro, Uberaba, Minas Gerais, Brazil
- Department of Neurology, Psychology, and Psychiatry, Botucatu Medical School, Botucatu, Sao Paulo, Brazil
open access
Vol 57, No 1 (2023)
INVITED EDITORIALS — LEADING TOPIC
Submitted: 2022-11-30
Accepted: 2022-12-02
Published online: 2022-12-14
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Invited Editorial
Pages
8-10
Published online
2022-12-14
Page views
2798
Article views/downloads
575
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2023;57(1):8-10.
Authors
Gustavo José Luvizutto
Rodrigo Bazan
References (26)- Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol. 2020; 267(6): 1573–1576.
- Zhou Z, Kang H, Li S, et al. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020; 267(8): 2179–2184.
- Desforges M, Le Coupanec A, Brison E, et al. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol. 2014; 807: 75–96.
- Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019; 12(1).
- Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021; 268(9): 3059–3071.
- Burle B, Spieser L, Roger C, et al. Spatial and temporal resolutions of EEG: Is it really black and white? A scalp current density view. Int J Psychophysiol. 2015; 97(3): 210–220.
- Antony AR, Haneef Z. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 2020; 83: 234–241.
- Galanopoulou AS, Ferastraoaru V, Correa DJ, et al. EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report. Epilepsia Open. 2020; 17;5(2): 314–324.
- Vellieux G, Rouvel-Tallec A, Jaquet P, et al. COVID-19 associated encephalopathy: Is there a specific EEG pattern? Clin Neurophysiol. 2020; 131(8): 1928–1930.
- Bosak M, Mazurkiewicz I, Włoch-Kopeć D, et al. High prevalence of electroencephalographic frontal intermittent rhythmic delta activity in patients with moderately severe COVID-19. Neurol Neurochir Pol. 2022 [Epub ahead of print].
- Gogia B, Thottempudi N, Ajam Y, et al. EEG characteristics in COVID-19 survivors and non-survivors with seizures and encephalopathy. Cureus. 2021; 13(10): e18476.
- Cecchetti G, Agosta F, Canu E, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. 2022; 269(7): 3400–3412.
- Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020; 19(11): 919–929.
- Yong SJ. Persistent brainstem dysfunction in long-covid: a hypothesis. ACS Chem Neurosci. 2021; 12(4): 573–580.
- Ricceri L, Minghetti L, Moles A, et al. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp Neurol. 2004; 189(1): 162–172.
- Osipova D, Ahveninen J, Kaakkola S, et al. Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin Neurophysiol. 2003; 114(10): 1902–1907.
- Harmony T. The functional significance of delta oscillations in cognitive processing. Front Integr Neurosci. 2013; 7: 83.
- Andrei Appelt P, Taciana Sisconetto A, Baldo Sucupira KS, et al. Changes in electrical brain activity and cognitive functions following mild to moderate COVID-19: a one-Year prospective study after acute infection. Clin EEG Neurosci. 2022; 53(6): 543–557.
- Sanabria-Diaz G, Etter MM, Melie-Garcia L, et al. Brain cortical alterations in COVID-19 patients with neurological symptoms. Front Neurosci. 2022; 16: 992165.
- Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. 2022; 604(7907): 697–707.
- Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021; 144(4): 1263–1276.
- Esposito F, Cirillo M, De Micco R, et al. Olfactory loss and brain connectivity after COVID-19. Hum Brain Mapp. 2022; 43(5): 1548–1560.
- Uncini A, Foresti C, Frigeni B, et al. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection. Neurophysiol Clin. 2021; 51(2): 183–191.
- Daia C, Scheau C, Neagu G, et al. Nerve conduction study and electromyography findings in patients recovering from Covid-19 — Case report. Int J Infect Dis. 2021; 103: 420–422.
- Rosato C, Bolondi G, Russo E, et al. Clinical, electromyographical, histopathological characteristics of COVID-19 related rhabdomyolysis. SAGE Open Med Case Rep. 2020; 8: 2050313X20983132.
- Fernandez CE, Franz CK, Ko JH, et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021; 298(3): E117–E130.
